Reports by Industry

Pharmaceuticals Market Reports

Global Pharmaceutical Raw Material Testing & Analytics Market Size, Trends & Analysis - Forecasts to 2027 By Pharmaceutical Type (Small Molecules, Large Molecules), By Service (Physicochemical Properties Testing, Identity & Purity Testing), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

The Global Pharmaceutical Raw Material Testing & Analytics Market is projected to grow at a CAGR value of 7.6% from 2022 to 2027. Read More »
May 26 : 2022

Global Pulmonary Arterial Hypertension Market Size, Trends & Analysis - Forecasts to 2027 By Drug Class (Endothelin Receptor Antagonists (ERAs), PDE - 5 Inhibitors, Prostacyclin & Prostacyclin Analogs, SGC Stimulators), By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/Subcutaneous, Inhalational), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

The Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR value of 5.2% from 2022 to 2027. Read More »
May 9 : 2022

Global Complementary & Alternative Cancer Treatment Market Size, Trends & Analysis - Forecasts to 2027 By Intervention Type (Acupuncture or Acupressure, Reiki Or Therapeutic/ Healing Touch, Yoga, Tai Chi Or Qi Gong, Hormone Therapies, Health Supplements, Emotional & Spiritual Healing, Others), By Indication (Breast Cancer, Ovarian Cancer, Cervical Cancer, Lung Cancer, Colorectal Cancer, Gastrointestinal Cancer, and Others), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

The global complementary & alternative cancer treatment market is projected to grow at a CAGR value of 21.8% from 2022 to 2027. Read More »
May 2 : 2022

Global Oncology Antibody Drug Conjugates Market Size, Trends & Analysis - Forecasts to 2027 By Indication (Breast Cancer, Ovarian Cancer, Cervical Cancer, NSCLC, Colorectal Cancer, Pancreatic Cancer, Hodgkin Lymphoma, Leukemia, Gastric Cancer), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

The Global Oncology Antibody Drug Conjugates Market is projected to grow from USD 9.87 billion in 2022 to USD 22.48 billion at a CAGR value of 12.4% from 2022 to 2027. Read More »
April 28 : 2022

Global Neurological Disorder Drugs Market Size, Trends & Analysis - Forecasts to 2027 By Indication (Epilepsy, Alzheimers disease, Parkinsons disease, Multiple Sclerosis, Cerebrovascular disease, and others), By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant and others), By Route of Administration (Oral, Parenteral, Others), By End-Users (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

The Global Neurological Disorder Drugs Market is projected to grow at a CAGR value of 5.6% from 2022 to 2027. Read More »
April 21 : 2022

Global Infectious Vaccines Market Size, Trends & Analysis - Forecasts to 2027 By Technology (Conjugate vaccines, Inactivated & Subunit vaccines, Live Attenuated vaccines, Recombinant vaccines, Toxoid vaccines Viral vector vaccines, and COVID-19 Vaccines) By Type (Monovalent vaccines and Multivalent vaccines) By Disease Indication (Influenza, Pneumococcal diseases, Combination vaccines, HPV, Herpes Zoster, Meningococcal diseases, Rotavirus, MMR, Varicella, Hepatitis, DTP, Polio, COVID 19, and Other disease indications), By Route of Administration (Intramuscular & Subcutaneous administration, Oral administration and Other routes of administration) By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

The global infectious vaccines market is projected to grow at a CAGR value of 12.5% from 2022 to 2027. Read More »
April 21 : 2022

Global Companion Animal Pharmaceuticals Market Size, Trends & Analysis - Forecasts to 2027 By Indication (Infectious Diseases, Dermatologic Diseases, Pain, Orthopedic Diseases, Behavioral Diseases, Other Indications), By Animal Type (Dogs, Cats, Horses, Other Companion Animals), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

The Global Companion Animal Pharmaceuticals Market is projected to grow from USD 13.2 billion in 2022 to USD 19.5 billion by 2027 at a CAGR value of 7.8% from 2022 to 2027. Read More »
April 18 : 2022

Global Plasmid DNA Manufacturing Market Size, Trends & Analysis - Forecasts to 2027 By Step Scope (Process Development, cGMP Manufacturing, QC and Analytical, Others), By Scale Scope (Research-Grade Plasmid, Industrial Grade, Others), By Application Scope (Cell & Gene Therapy Manufacturing, Vaccines Development, Viral Vector Manufacturing, Research Applications), By End-use Scope (Pharmaceutical and Biopharmaceutical Companies, Government & Academic Research Institutes), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

The Global Plasmid DNA Manufacturing Market is projected to grow at a CAGR value of 24.5% from 2022 to 2027. Read More »
April 4 : 2022

Global Inactivated Vaccine Market Size, Trends & Analysis - Forecasts to 2027 By Vaccine Type (Viral Vaccine and Bacterial Vaccine) By Method of Inactivation (Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, and Others), By Route of Administration (Oral, Subcutaneous, Intravenous, and Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

The global inactivated vaccines market is projected to grow at a CAGR value of 10.5% from 2022 to 2027. Read More »
March 31 : 2022

Global Viral Vector Manufacturing Market Size, Trends & Analysis - Forecasts to 2027 By Type (Retroviral Vectors, Adenoviral Vectors, Adeno-associated Viral Vectors, Other Viral Vectors), By Disease (Cancers, Genetic Disorders, Infectious diseases, Other Diseases), By Application (Gene Therapy and Vaccinology), By End-User (Pharmaceutical and Bio-pharmaceutical Companies, and Research Institutes), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Company Market Share Analysis, and Competitor Analysis

The global viral vector manufacturing market is projected to grow at a CAGR value of 20.5% from 2022 to 2027. Read More »
March 31 : 2022